Peptide Offer Market
AN OPEN BOOK ON OFFERS

Names before numbers

Know which offer you are reading.

A product-identity guide to CoreAge Rx’s peptide promotions, helping readers keep single preparations, blends, campaign pages and final prescription details distinct before comparing the advertised commercial terms.

Explore the details
THOUGHTFUL READING FOR A BUSY SEASON

The reading room

A little context goes a long way.

01

A single preparation and a blend need separate notes

Keep product identity intact when a campaign uses nicknames, ingredient names and optional variants alongside similar plan language and the same seasonal promotion.

02

Keep the offer matched to its product page

Use a simple document trail to avoid carrying a price, availability statement or product description from one preparation into a different offer by mistake.

Sponsored · CoreAge Rx

The offer, with the details attached.

Prices below are advertised by CoreAge Rx. Confirm eligibility, current terms, and total charges with the provider before enrolling.

Advertised Black Friday terms

Epithalon

$99.50monthly equivalent

$597 billed upfront for six months

Advertised through November 27, 2026, at 11:59 p.m. Eastern. Confirm current checkout, cancellation and renewal terms.

  • Provider approval required. This is a six-month prepaid commitment.
  • The general product page says “Coming soon”; confirm enrollment with CoreAge Rx.
View CoreAge Rx details

Compounded and not FDA-approved. Human evidence is limited; discuss risks and suitability with a licensed clinician.

Provider source

Advertised Black Friday terms

MOTS-C

$99.50monthly equivalent

$597 billed upfront for six months

Advertised through November 27, 2026, at 11:59 p.m. Eastern. Confirm current checkout, cancellation and renewal terms.

  • Provider approval required. This is a six-month prepaid commitment.
  • The general product page says “Coming soon”; confirm enrollment with CoreAge Rx.
View CoreAge Rx details

Compounded and not FDA-approved. Human evidence is limited; discuss risks and suitability with a licensed clinician.

Provider source

Advertised Black Friday terms

BPC-157

$99.50monthly equivalent

$597 billed upfront for six months

Advertised through November 27, 2026, at 11:59 p.m. Eastern. Confirm current checkout, cancellation and renewal terms.

  • Provider approval required. This is a six-month prepaid commitment.
  • The general product page says “Coming soon”; confirm enrollment with CoreAge Rx.
View CoreAge Rx details

Compounded and not FDA-approved. Human evidence is limited; discuss risks and suitability with a licensed clinician.

Provider source

Advertised Black Friday terms

Wolverine Stack

$124.50monthly equivalent

$747 billed upfront for six months

Advertised through November 27, 2026, at 11:59 p.m. Eastern. Confirm current checkout, cancellation and renewal terms.

  • Provider approval required. This is a six-month prepaid commitment.
  • Provider describes a BPC-157 + TB-500 blend.
View CoreAge Rx details

Compounded and not FDA-approved. Human evidence is limited; discuss risks and suitability with a licensed clinician.

Provider source

Promotional placement. This publication is part of a commonly owned promotional network supporting CoreAge Rx. Placement is not an independent ranking or a claim that treatment is appropriate for you. How this site works.

Take this with you

Your conversation checklist.

  1. Is this the single preparation or a named blend?

  2. Does the page describe another variant separately?

  3. Will the selected order identify the exact formulation?

  4. Who can confirm the relationship between the offer and the prescription?

A closer look

Keep the product name attached to the terms

Similar offer language can sit above very different product names. This market begins with identity: which preparation the page describes, whether more than one ingredient is named, and which variant the reader actually selected. It is a way to organize the conversation, not a menu that decides what someone should take.

CoreAge Rx is the promoted provider on these pages. The November 7, 2026 source check found live campaigns, but general Epithalon, MOTS-C and BPC-157 listings still say Coming soon. A named offer therefore needs both an availability check and an individual clinical assessment before it can become an actual prescription.

Before you decide

Questions worth asking.

01Is the Wolverine Stack another name for BPC-157 alone?

CoreAge Rx describes its Wolverine Stack campaign as a blend of BPC-157 and TB-500. Its BPC-157 campaign describes a different named preparation. Keep those identities separate when reading prices; the shared ingredient does not make the offers interchangeable.

02Can two variants share an advertised price?

The Wolverine Stack page mentions a version with KPV at the same advertised price. That commercial statement does not make the formulations identical. Ask the provider which variant is selected and let the clinician determine whether any option is appropriate.

03Does this directory compare treatment effectiveness?

No. It compares the way offers are identified and documented. We do not assign clinical advantages to a single preparation or blend. Compounded products are not FDA-approved, and provider advertising does not establish a benefit for an individual reader.

04Why retain the full preparation name in my notes?

A short nickname can lose information when copied into a budget or message. Keeping the complete name and its source link makes it easier to ask the provider about the correct offer, especially when a page includes more than one variant.